KDM4A and breast cancer: Additionally, the expression levels of FYN and KDM4A were found to be correlated with poor prognosis in a previously reported breast cancer cohort (Hatzis et al., 2011), highlighting the potential of targeting these two genes as therapeutic targets for TNBC (Figure 4C).